VERV   $5.58  -7.15% Market Open

Verve Therapeutics Inc
Total Cash 575.95M
totalCashPerShare 6.806
EBITDA -215.68M
Total Debt 72.48M
quickRatio 14.343
currentRatio 14.638
Total Revenue 20.65M
debtToEquity 13.272
Revenue/Share 0.275
ROA -0.21508
ROE -0.38099
grossProfits
freeCashflow -94.29M
operatingCashflow -129.73M
earningsGrowth
revenueGrowth 2.197
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -8.79244
profitMargins 0.0
enterpriseValue 8.51M
forwardPE -2.2650177
floatShares 62.40M
sharesOutstanding 84.66M
sharesShort 17.44M
sharesShortPriorMonth 15.87M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.89%
Short Ratio help_outline 14.14%
shortPercentOfFloat 0.25%
impliedSharesOutstanding
bookValue 7.314
Price To Book help_outline 0.88
earningsQuarterlyGrowth
netIncomeToCommon -192.65M
trailingEps -2.48%
forwardEps -2.83%
enterpriseToEbitda -0.04
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.7 4Q 2024
institutionsCount 241
lastUpdated Nov. 7, 2024, 5:08 a.m.